Android app Apple app link

Ascendis Pharma A/S (ASND) Analyst Forecast

NASDAQ Currency in USD Disclaimer
Add to Alerts ADD TO LIST

$140.28

south_east
-$0.12 (-0.09%)
Day's range
$136.73
Day's range
$141.48

Recent Analyst Forecasts and Stock Ratings

Date Brokerage Firm Analyst Name Price Target Price when Posted Upside/Downside
on Report Date		 Details
09/23/2024 Bank of America Securities Tazeen Ahmad $191.00 $151.26   26.27%
09/17/2024 Evercore ISI Gavin Clark-Gartner $205.00 $144.97   41.41%
09/17/2024 Oppenheimer Leland Gershell $190.00 $143.90   32.04%
09/17/2024 Citigroup David Lebowitz $207.00 $139.57   48.31%
09/17/2024 Wells Fargo Derek Archila $289.00 $139.57   107.06%
09/16/2024 Bank of America Securities Tazeen Ahmad $175.00 $142.26   23.01%
09/16/2024 Goldman Sachs Paul Choi $200.00 $142.26   40.59%
09/13/2024 Citigroup David Lebowitz $178.00 $118.00   50.85%
09/05/2024 Oppenheimer Leland Gershell $180.00 $122.40   47.06%
08/13/2024 Jefferies Kelly Shi $196.00 $128.48   52.55%
05/30/2024 Stifel Nicolaus Alex Thompson $200.00 $137.45   45.51%
05/15/2024 Morgan Stanley Vikram Purohit $140.00 $124.04   12.87%
03/14/2024 Evercore ISI Josh Schimmer $191.00 $149.89   27.43%
02/27/2022 Citigroup David Lebovitz $187.00 $112.39   66.38%
01/05/2022 Cowen & Co. Yaron Werber $136.00 $121.70   11.75%
07/06/2021 Canaccord Genuity Michelle Gilson $196.00 $126.68   54.72%
06/13/2021 Cantor Fitzgerald Alethia Young $201.00 $134.40   49.55%

Ascendis Pharma A/S FAQ's

Ascendis Pharma A/S has been rated by research analysts at Morgan Stanley, Bank of America Securities, Evercore ISI, Oppenheimer, Citigroup, Wells Fargo in the past 90 days.

Premium Content

This content is only available for premium members. Please become a paid member to access.

Download App

Currently, memberships can only be purchased through the app.